Jane Street
LPCN icon

Jane Street’s Lipocine LPCN Stock Holding History

Jane Street’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$244K Buy
95,227
+75,200
+375% +$181K ﹤0.01% 9664
2026
Q1 		$160K Buy
20,027
+9,453
+89% +$82.4K ﹤0.01% 10336
2025
Q4 		$84.9K Buy
+10,574
New +$35.6K ﹤0.01% 10265
2023
Q2 		– Sell
-2,404
Closed -$13K – 9201
2023
Q1 		$13K Buy
2,404
+1,433
+148% +$11.1K ﹤0.01% 8710
2022
Q4 		$6.57K Sell
971
-884
-48% -$6.44K ﹤0.01% 8826
2022
Q3 		$14K Buy
1,855
+274
+17% +$3.06K ﹤0.01% 9274
2022
Q2 		$22K Sell
1,581
-228
-13% -$3.55K ﹤0.01% 9136
2022
Q1 		$42K Buy
1,809
+477
+36% +$9.98K ﹤0.01% 9745
2021
Q4 		$22K Sell
1,332
-873
-40% -$16.2K ﹤0.01% 9773
2021
Q3 		$41K Buy
+2,205
New +$48.7K ﹤0.01% 9611
2021
Q2 		– Sell
-1,709
Closed -$44K – 10142
2021
Q1 		$44K Buy
+1,709
New +$49.3K ﹤0.01% 8861
2017
Q3 		– Sell
-1,440
Closed -$98K – 4813
2017
Q2 		$98K Buy
+1,440
New +$93.9K ﹤0.01% 4167

Other funds holding LPCN

SCM
Squadron Capital Management Westmont, Illinois $322M AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $606M AUM

Jane Street's LPCN Position: Q2 2026 in Review

Jane Street increased its Lipocine (LPCN) stake by 375% in Q2 2026, buying an estimated $181K and bringing the position to 95,227 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #9664.

Jane Street first reported a position in LPCN in Q2 2017 and has held it in 12 quarters since. 36 funds tracked by Wall St. Rank hold LPCN as of Q2 2026.

  • Jane Street held 95,227 shares of Lipocine worth $244K as of Q2 2026.
  • Jane Street bought 75,200 Lipocine shares in Q2 2026, an estimated $181K.
  • Lipocine made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #9664 holding.
  • Jane Street first reported a position in Lipocine in Q2 2017 and has held it in 12 quarters since.
  • 36 funds tracked by Wall St. Rank held Lipocine as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.